We are live on
!
Find out more
OASM
Oasmia Pharmaceutical AB
OASM
OASM
Delisted
OASM was delisted on the 21st of August, 2019.
0 hedge funds and large institutions have $0 invested in Oasmia Pharmaceutical AB in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $38K → $0 (-$38K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$33K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| 3 |
FIA
FNY Investment Advisers
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CLOS
1
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | -$33K | -33,300 | Closed |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$3K | -2,723 | Closed |
|
|
FIA
3
FNY Investment Advisers
New York
| – | -$2K | -2,600 | Closed |
|